Accessibility Menu
 

Genelux

(NASDAQ) GNLX

Current Price$2.66
Market Cap$118.29M
Since IPO (2023)-57%
5 YearN/A
1 Year+27%
1 Month-7%

Genelux Financials at a Glance

Market Cap

$118.29M

Revenue (TTM)

$8.00K

Net Income (TTM)

$32.15M

EPS (TTM)

$-0.87

P/E Ratio

-3.05

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$2.66

Volume

3,291

Open

$2.71

Previous Close

$2.66

Daily Range

$2.63 - $2.71

52-Week Range

$2.21 - $8.54

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genelux

Industry

Biotechnology

Employees

26

CEO

Thomas D. Zindrick

Headquarters

Westlake Village, CA 91361, US

GNLX Financials

Key Financial Metrics (TTM)

Gross Margin

-35%

Operating Margin

-4152%

Net Income Margin

-4018%

Return on Equity

-170%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-32.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$118.29M

Shares Outstanding

44.81M

Volume

3.29K

Short Interest

0.00%

Avg. Volume

218.74K

Financials (TTM)

Gross Profit

$566.00K

Operating Income

$33.21M

EBITDA

$32.64M

Operating Cash Flow

$25.27M

Capital Expenditure

$1.10M

Free Cash Flow

$26.37M

Cash & ST Invst.

$14.60M

Total Debt

$1.69M

Genelux Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$8.00K

N/A

Gross Profit

$140.00K

N/A

Gross Margin

-17.50%

N/A

Market Cap

$118.29M

N/A

Market Cap/Employee

$4.93M

N/A

Employees

24

N/A

Net Income

$9.25M

-3.0%

EBITDA

$9.84M

-12.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$12.91M

-55.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.26M

-18.3%

Short Term Debt

$427.00K

+29.8%

Return on Assets

-1.69%

N/A

Return on Invested Capital

-2.59%

N/A

Free Cash Flow

$6.63M

-50.9%

Operating Cash Flow

$6.20M

-44.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALDXAldeyra Therapeutics, Inc.
$1.57+3.29%
MREOMereo BioPharma Group plc
$0.32-2.33%
CADLCandel Therapeutics, Inc.
$4.95+0.00%
SLNSilence Therapeutics plc
$5.85+4.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.29-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$69.20-0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.00+0.09%
NOKNokia
$9.44+0.07%

Questions About GNLX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.